Nicholas Champion, MD
Surgical Oncology · Tampa, FLNPI 1659806644
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $2,363 of the $3,750 with a category attached, or 63.0%. Elucent Medical accounts for 70.7% of it on its own, with 7 other manufacturers making up the rest. 2025 is the largest year on record at $2,975, 4.8 times the $626 reported in 2023.
Across 19 payments — averaging $197.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Elucent Medical$3K
- Dilon Technologies, Inc.$389
- Endomagnetics Ltd$195
- Stryker$195
- Hologic Inc$141
- Solventum Corporation$119
- plus $59 from 2 others
What the payments were for
- Consulting fees$2,36363%
- Travel & lodging$983%
- Food & beverage$1,23833%
- Entertainment$511%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Elucent Medical | 6 | $2,652 |
| Dilon Technologies, Inc. | 3 | $389 |
| Endomagnetics Ltd | 1 | $195 |
| Stryker | 2 | $195 |
| Hologic Inc | 2 | $141 |
| Solventum Corporation | 3 | $119 |
| Johnson & Johnson | 1 | $39 |
| Medtronic | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- HemoBlast Bellows$317
- Magseed$195
- Magtrace$195
- MOLLI$161
How this compares
$3,750 in reported general payments places this provider in the 60th percentile of 133 surgical oncology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Doxycycline Hyclate | 17 | $97 |
| Tramadol Hcl | 52 | $59 |
Paid to pharmacies, not to this prescriber.
Other surgical oncology in Tampa
- Jonathan ZagerTampa$191K
- Pamela HodulTampa$94K
- Charles CoxTampa$24K
- Jason FlemingTampa$14K
- Ricardo GonzalezTampa$7K
- Neha GoelMiami$200K
- Horacio AsbunMiami$161K
- Adrian Legaspi SauterHialeah$116K
- Kenneth MeredithSarasota$113K
- Mehran HabibiMiami$73K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.